How special is a pathogenic CNS autoantigen? Immunization to many CNS self-antigens does not induce autoimmune disease

Journal of Neuroimmunology

Volumn 174, Issue 1-2, 2006, Pages 3-11

  Mor, Felix ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alzheimer's disease; Autoimmunity; EAE; Peptides

Indexed keywords

AUTOANTIGEN; BETA SYNUCLEIN; BRAIN PROTEIN; CELL SURFACE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; STRUCTURAL PROTEIN; SYNAPSE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BRAIN DISEASE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMULSION; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREGULATION; INCIDENCE; LABORATORY; LYMPHOID CELL LINE; MOUSE; NEUROPROTECTION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CLONE CELLS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; MICE; MICE, INBRED NOD; RATS; RATS, INBRED LEW; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 33646110521     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.12.003     Document Type: Article

References (47)

1. Billiau A., and Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukoc. Biol. 70 (2001) 849-860
2. Birmingham K., and Franz S. Set back to Alzheimer vaccine studies. Nat. Med. 8 (2002) 199-200
3. Cohen I.R. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu. Rev. Immunol. 9 (1991) 567-589
4. Cohen I.R. The cognitive paradigm and the immunological homunculus. Immunol. Today 13 (1992) 490-494
5. Drakesmith H., O'Neil D., Schneider S.C., Binks M., Medd P., Sercarz E., Beverley P., and Chain B. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14903-14908
6. Eisenbarth G.S. Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes. Ann. N. Y. Acad. Sci. 1005 (2003) 109-118
7. Eylar E.H., Salk J., Beveridge G.C., and Brown L.V. Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin. Arch. Biochem. Biophys. 132 (1969) 34-48
8. Fountoulakis M. Application of proteomics technologies in the investigation of the brain. Mass Spectrom. Rev. 23 (2004) 231-258
9. Furlan R., Brambilla E., Sanvito F., Roccatagliata L., Olivieri S., Bergami A., Pluchino S., Uccelli A., Comi G., and Martino G. Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain 126 (2003) 285-291
10. Gauss C., Kalkum M., Lowe M., Lehrach H., and Klose J. Analysis of the mouse proteome: (I). Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis 20 (1999) 575-600
11. Helmuth L. Alzheimer's congress. Further progress on a beta-amyloid vaccine. Science 289 (2000) 375
12. Hertl M., and Veldman C. T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin. Autoimmun. Rev. 2 (2003) 278-283
13. Hoedemaekers A.C., van Breda Vriesman P.J., and De Baets M.H. Myasthenia gravis as a prototype autoimmune receptor disease. Immunol. Res. 16 (1997) 341-354
14. Hofstetter H.H., Shive C.L., and Forsthuber T.G. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 169 (2002) 117-125
15. Ichikawa M., Koh C.S., Inoue A., Tsuyusaki J., Yamazaki M., Inaba Y., Sekiguchi Y., Itoh M., Yagita H., and Komiyama A. Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing-remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. J. Neuroimmunol. 102 (2000) 56-66
16. Kabat E., Wolf A., and Bezer A. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. Exp. Med. 85 (1947) 117-129
17. Kawakami N., Nagerl U.V., Odoardi F., Bonhoeffer T., Wekerle H., and Flugel A. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J. Exp. Med. 201 (2005) 1805-1814
18. Klose J., Nock C., Herrmann M., Stuhler K., Marcus K., Bluggel M., Krause E., Schalkwyk L.C., Rastan S., Brown S.D., Bussow K., Himmelbauer H., and Lehrach H. Genetic analysis of the mouse brain proteome. Nat. Genet. 30 (2002) 385-393
19. Kojima K., Berger T., Lassmann H., Hinze-Selch D., Zhang Y., Gehrmann J., Reske K., Wekerle H., and Linington C. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180 (1994) 817-829
20. Lafaille J.J. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9 (1998) 139-151
21. Lee B., and Craft J.E. Molecular structure and function of autoantigens in systemic sclerosis. Int. Rev. Immunol 12 (1995) 129-144
22. Maatta J.A., Kaldman M.S., Sakoda S., Salmi A.A., and Hinkkanen A.E. Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase for BALB/c and SJL mice. Immunology 95 (1998) 383-388
23. Magri G., Clerici M., Dall'Ara P., Biasin M., Caramelli M., Casalone C., Giannino M.L., Longhi R., Piacentini L., Della Bella S., Gazzuola P., Martino P.A., Pollera C., Puricelli M., Servida F., Crescio I., Boasso A., Ponti W., and Poli G. Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. Vaccine 23 (2005) 2862-2868
24. Matsumoto I., Maccioni M., Lee D.M., Maurice M., Simmons B., Brenner M., Mathis D., and Benoist C. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3 (2002) 360-365
25. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5 (1999) 49-55
26. Mor F., and Cohen I.R. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 92 (1993) 2199-2206
27. Mor F., and Cohen I.R. Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. J. Immunol. 155 (1995) 3693-3699
28. Mor F., and Cohen I.R. Propagation of lewis rat encephalitogenic T cell lines: T-cell-growth-factor is superior to recombinant IL-2. J. Neuroimmunol. 123 (2002) 76-82
29. Mor F., Lohse A.W., Karin N., and Cohen I.R. Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen. J. Clin. Invest. 85 (1990) 1594-1598
30. Mor F., Reizis B., Cohen I.R., and Steinman L. IL-2 and TNF receptors as targets of regulatory T-T interactions: isolation and characterization of cytokine receptor-reactive T cell lines in the Lewis rat. J. Immunol. 157 (1996) 4855-4861
31. Mor F., Kantorowitz M., and Cohen I.R. Selection of anti-myelin basic protein T-cell lines in the Lewis rat: V-beta 8.2 dominance and conserved complementarity-determining-region-3 motifs are dependent on serine at position 78 of myelin basic protein. J. Neuroimmunol. 106 (2000) 154-164
32. Mor F., Quintana F., Mimran A., and Cohen I.R. Autoimmune encephalomyelitis and uveitis induced by T cell immunity to self beta-synuclein. J. Immunol. 170 (2003) 628-634
33. Pitkanen J., and Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 4 (2003) 12-21
34. Rammensee H.G. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7 (1995) 85-96
35. Reizis B., Mor F., Eisenstein M., Schild H., Stefanovic S., Rammensee H.G., and Cohen I.R. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI. Int. Immunol. 8 (1996) 1825-1832
36. Reizis B., Eisenstein M., Bockova J., Konen-Waisman S., Mor F., Elias D., and Cohen I.R. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. Int. Immunol. 9 (1997) 43-51
37. Reizis B., Eisenstein M., Mor F., and Cohen I.R. The peptide-binding strategy of the MHC class II I-A molecules. Immunol. Today 19 (1998) 212-216
38. Rivers T., Sprunt D., and Berry G. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58 (1933) 39-53
39. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
40. Schmidt S. Candidate autoantigens in multiple sclerosis. Mult. Scler. 5 (1999) 147-160
41. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., and Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11 (1993) 729-766
42. Steinman L. Multiple sclerosis. Presenting an odd autoantigen. Nature 375 (1995) 739-740
43. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., and Linington C. Animal models. Ann. Neurol. 36 Suppl (1994) S47-S53
44. Whitham R.H., Bourdette D.N., Hashim G.A., Herndon R.M., Ilg R.C., Vandenbark A.A., and Offner H. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146 (1991) 101-107
45. Williams W.V., Kyriakos M., Sharp G.C., and Braley-Mullen H. Augmentation of transfer of experimental autoimmune thyroiditis (EAT) in mice by irradiation of recipients. Cell. Immunol. 109 (1987) 397-406
46. Yoshimura T., Kunishita T., Sakai K., Endoh M., Namikawa T., and Tabira T. Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein. J. Neurol. Sci. 69 (1985) 47-58
47. Yu L.R., Conrads T.P., Uo T., Kinoshita Y., Morrison R.S., Lucas D.A., Chan K.C., Blonder J., Issaq H.J., and Veenstra T.D. Global analysis of the cortical neuron proteome. Mol. Cell. Proteomics 3 (2004) 896-907